{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T13:01:01Z","timestamp":1790168461780,"version":"4.1.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T00:00:00Z","timestamp":1782345600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T00:00:00Z","timestamp":1790121600000},"content-version":"vor","delay-in-days":90,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Discov Ment Health"],"DOI":"10.1007\/s44192-026-00524-2","type":"journal-article","created":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T13:35:18Z","timestamp":1782394518000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Clinical and literature insights into the frontotemporal dementia and motor neuron disease spectrum"],"prefix":"10.1007","volume":"6","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3384-5320","authenticated-orcid":false,"given":"Faezeh","family":"Khorshidian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5057-8028","authenticated-orcid":false,"given":"Zahra","family":"Vahabi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Setareh","family":"Rassa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3307-5511","authenticated-orcid":false,"given":"Mohammadreza","family":"Mousavipour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,25]]},"reference":[{"issue":"6","key":"524_CR1","doi-asserted-by":"publisher","first-page":"1546","DOI":"10.1212\/wnl.51.6.1546","volume":"51","author":"D Neary","year":"1998","unstructured":"Neary D, Snowden JS, Gustafson L, Passant U, Stuss D, Black SASA, et al. Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria. Neurology. 1998;51(6):1546\u201354. https:\/\/doi.org\/10.1212\/wnl.51.6.1546.","journal-title":"Neurology"},{"issue":"10","key":"524_CR2","doi-asserted-by":"publisher","first-page":"1918","DOI":"10.1111\/ene.14393","volume":"27","author":"P Masrori","year":"2020","unstructured":"Masrori P, Van Damme P. Amyotrophic lateral sclerosis: a clinical review. Eur J Neurol. 2020;27(10):1918\u201329. https:\/\/doi.org\/10.1111\/ene.14393.","journal-title":"Eur J Neurol"},{"issue":"11","key":"524_CR3","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1212\/WNL.0b013e31821103e6","volume":"76","author":"ML Gorno-Tempini","year":"2011","unstructured":"Gorno-Tempini ML, Hillis AE, Weintraub S, Kertesz A, Mendez M, Cappa SF, et al. Classification of primary progressive aphasia and its variants. Neurology. 2011;76(11):1006\u201314. https:\/\/doi.org\/10.1212\/WNL.0b013e31821103e6.","journal-title":"Neurology"},{"issue":"8","key":"524_CR4","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1136\/jnnp-2016-314912","volume":"88","author":"JA Saxon","year":"2017","unstructured":"Saxon JA, Harris JM, Thompson JC, Jones M, Richardson AM, Langheinrich T, et al. Semantic dementia, progressive non-fluent aphasia and their association with amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry. 2017;88(8):711\u20132. https:\/\/doi.org\/10.1136\/jnnp-2016-314912.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"9","key":"524_CR5","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1038\/s41582-018-0047-2","volume":"14","author":"R Balendra","year":"2018","unstructured":"Balendra R, Isaacs AM. C9orf72-mediated ALS and FTD: multiple pathways to disease. Nat Rev Neurol. 2018;14(9):544\u201358. https:\/\/doi.org\/10.1038\/s41582-018-0047-2.","journal-title":"Nat Rev Neurol"},{"issue":"9","key":"524_CR6","doi-asserted-by":"publisher","first-page":"2456","DOI":"10.1093\/brain\/awr179","volume":"134","author":"K Rascovsky","year":"2011","unstructured":"Rascovsky K, Hodges JR, Knopman D, Mendez MF, Kramer JH, Neuhaus J, et al. Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia. Brain. 2011;134(9):2456\u201377. https:\/\/doi.org\/10.1093\/brain\/awr179.","journal-title":"Brain"},{"issue":"3","key":"524_CR7","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1007\/s00401-014-1253-7","volume":"127","author":"IO Woollacott","year":"2014","unstructured":"Woollacott IO, Mead S. The C9ORF72 expansion mutation: gene structure, phenotypic and diagnostic issues. Acta Neuropathol. 2014;127(3):319\u201332. https:\/\/doi.org\/10.1007\/s00401-014-1253-7.","journal-title":"Acta Neuropathol"},{"issue":"1","key":"524_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.psycr.2022.100082","volume":"2","author":"P Wibawa","year":"2023","unstructured":"Wibawa P, O\u2019Connor R, Kenchaiah B, Velakoulis D. Motor neuron disease & frontotemporal dementia presenting with a conversion disorder. Psychiatry Res Case Rep. 2023;2(1):100082. https:\/\/doi.org\/10.1016\/j.psycr.2022.100082.","journal-title":"Psychiatry Res Case Rep"},{"issue":"1","key":"524_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/WNN.0000000000000217","volume":"33","author":"C Trieu","year":"2020","unstructured":"Trieu C, Gossink F, Stek ML, Scheltens P, Pijnenburg YA, Dols A. Effectiveness of pharmacological interventions for symptoms of behavioral variant frontotemporal dementia: a systematic review. Cogn Behav Neurol. 2020;33(1):1\u201315. https:\/\/doi.org\/10.1097\/WNN.0000000000000217.","journal-title":"Cogn Behav Neurol"},{"issue":"9","key":"524_CR10","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1016\/j.jocn.2009.03.005","volume":"16","author":"P Lillo","year":"2009","unstructured":"Lillo P, Hodges JR. Frontotemporal dementia and motor neurone disease: overlapping clinic-pathological disorders. J Clin Neurosci. 2009;16(9):1131\u20135. https:\/\/doi.org\/10.1016\/j.jocn.2009.03.005.","journal-title":"J Clin Neurosci"},{"issue":"1","key":"524_CR11","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1007\/s00401-011-0845-8","volume":"122","author":"IR Mackenzie","year":"2011","unstructured":"Mackenzie IR, Neumann M, Baborie A, Sampathu DM, Du Plessis D, Jaros E, et al. A harmonized classification system for FTLD-TDP pathology. Acta Neuropathol. 2011;122(1):111\u20133. https:\/\/doi.org\/10.1007\/s00401-011-0845-8.","journal-title":"Acta Neuropathol"},{"issue":"2","key":"524_CR12","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1080\/13651500701867685","volume":"12","author":"S Sathasivam","year":"2008","unstructured":"Sathasivam S, Doran M, Larner AJ. Frontotemporal lobar degeneration with motor neurone disease (FTLD\/MND): presentations in psychiatric practice. Int J Psychiatry Clin Pract. 2008;12(2):138\u201341. https:\/\/doi.org\/10.1080\/13651500701867685.","journal-title":"Int J Psychiatry Clin Pract"},{"key":"524_CR13","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD013503.pub2","author":"N Davies","year":"2021","unstructured":"Davies N, Barrado-Martin Y, Vickerstaff V, Rait G, Fukui A, Candy B, et al. Enteral tube feeding for people with severe dementia. Cochrane Database Syst Rev. 2021. https:\/\/doi.org\/10.1002\/14651858.CD013503.pub2.","journal-title":"Cochrane Database Syst Rev"},{"issue":"6","key":"524_CR14","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1016\/S1474-4422(14)70090-0","volume":"13","author":"B Dubois","year":"2014","unstructured":"Dubois B, Feldman HH, Jacova C, Hampel H, Molinuevo JL, Blennow K, et al. Advancing research diagnostic criteria for Alzheimer\u2019s disease: the IWG-2 criteria. Lancet Neurol. 2014;13(6):614\u201329. https:\/\/doi.org\/10.1016\/S1474-4422(14)70090-0.","journal-title":"Lancet Neurol"},{"issue":"3","key":"524_CR15","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1212\/01.CON.0000466662.89908.e7","volume":"21","author":"DB Arciniegas","year":"2015","unstructured":"Arciniegas DB. Behavioral Neurology and Neuropsychiatry. Continuum (Minneap Minn). 2015;21(3):715\u201336.","journal-title":"Continuum (Minneap Minn)"},{"issue":"2","key":"524_CR16","doi-asserted-by":"publisher","first-page":"4437","DOI":"10.4088\/JCP.10m06382oli","volume":"72","author":"JD Woolley","year":"2011","unstructured":"Woolley JD, Khan BK, Murthy NK, Miller BL, Rankin KP. The diagnostic challenge of psychiatric symptoms in neurodegenerative disease: rates of and risk factors for prior psychiatric diagnosis in patients with early neurodegenerative disease. J Clin Psychiatry. 2011;72(2):4437. https:\/\/doi.org\/10.4088\/JCP.10m06382oli.","journal-title":"J Clin Psychiatry"},{"key":"524_CR17","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1097\/01.wad.0000183086.99691.91","volume":"19","author":"AL Boxer","year":"2005","unstructured":"Boxer AL, Miller BL. Clinical features of frontotemporal dementia. Alzheimer Dis Assoc Disord. 2005;19:S3\u20136. https:\/\/doi.org\/10.1097\/01.wad.0000183086.99691.91.","journal-title":"Alzheimer Dis Assoc Disord"},{"issue":"5","key":"524_CR18","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1212\/WNL.0b013e31827f0fd1","volume":"80","author":"MJ Armstrong","year":"2013","unstructured":"Armstrong MJ, Litvan I, Lang AE, Bak TH, Bhatia KP, Borroni B, et al. Criteria for the diagnosis of corticobasal degeneration. Neurology. 2013;80(5):496\u2013503. https:\/\/doi.org\/10.1212\/WNL.0b013e31827f0fd1.","journal-title":"Neurology"},{"issue":"1","key":"524_CR19","doi-asserted-by":"publisher","first-page":"e35","DOI":"10.1212\/WNL.0000000000009734","volume":"95","author":"N Sakae","year":"2020","unstructured":"Sakae N, Santos OA, Pedraza O, Litvan I, Murray ME, Duara R, et al. Clinical and pathologic features of cognitive-predominant corticobasal degeneration. Neurology. 2020;95(1):e35\u201345. https:\/\/doi.org\/10.1212\/WNL.0000000000009734.","journal-title":"Neurology"},{"issue":"7","key":"524_CR20","doi-asserted-by":"publisher","first-page":"2045","DOI":"10.1093\/brain\/awq123","volume":"133","author":"H Ling","year":"2010","unstructured":"Ling H, O\u2019Sullivan SS, Holton JL, Revesz T, Massey LA, Williams DR, et al. Does corticobasal degeneration exist? A clinicopathological re-evaluation. Brain. 2010;133(7):2045\u201357. https:\/\/doi.org\/10.1093\/brain\/awq123.","journal-title":"Brain"},{"issue":"6","key":"524_CR21","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1002\/mds.26987","volume":"32","author":"GU H\u00f6glinger","year":"2017","unstructured":"H\u00f6glinger GU, Respondek G, Stamelou M, Kurz C, Josephs KA, Lang AE, et al. Clinical diagnosis of progressive supranuclear palsy: the movement disorder society criteria. Mov Disord. 2017;32(6):853\u201364. https:\/\/doi.org\/10.1002\/mds.26987.","journal-title":"Mov Disord"},{"issue":"1","key":"524_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1212\/WNL.47.1.1","volume":"47","author":"I Litvan","year":"1996","unstructured":"Litvan I, Agid Y, Calne D, Campbell G, Dubois B, Duvoisin RC, et al. Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of the NINDS-SPSP international workshop. Neurology. 1996;47(1):1\u20139.","journal-title":"Neurology"},{"issue":"3","key":"524_CR23","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/S1474-4422(09)70042-0","volume":"8","author":"DR Williams","year":"2009","unstructured":"Williams DR, Lees AJ. Progressive supranuclear palsy: clinicopathological concepts and diagnostic challenges. Lancet Neurol. 2009;8(3):270\u20139. https:\/\/doi.org\/10.1016\/S1474-4422(09)70042-0.","journal-title":"Lancet Neurol"},{"issue":"1","key":"524_CR24","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1212\/WNL.0000000000004058","volume":"89","author":"G Halliday","year":"2017","unstructured":"Halliday G, Lewis S, Aarsland D, Attems J, Ballard CG, Boeve BF, et al. Diagnosis and management of dementia with Lewy bodies. Neurology. 2017;89(1):88\u2013100. https:\/\/doi.org\/10.1212\/WNL.0000000000004058.","journal-title":"Neurology"},{"issue":"10004","key":"524_CR25","doi-asserted-by":"publisher","first-page":"1683","DOI":"10.1016\/S0140-6736(15)00462-6","volume":"386","author":"Z Walker","year":"2015","unstructured":"Walker Z, Possin KL, Boeve BF, Aarsland D. Non-Alzheimer\u2019s dementia 2: Lewy body dementias. Lancet. 2015;386(10004):1683. https:\/\/doi.org\/10.1016\/S0140-6736(15)00462-6.","journal-title":"Lancet"},{"issue":"3","key":"524_CR26","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1093\/brain\/awh725","volume":"129","author":"P Tiraboschi","year":"2006","unstructured":"Tiraboschi P, Salmon DP, Hansen LA, Hofstetter RC, Thal LJ, Corey-Bloom J. What best differentiates Lewy body from Alzheimer\u2019s disease in early-stage dementia? Brain. 2006;129(3):729\u201335. https:\/\/doi.org\/10.1093\/brain\/awh725.","journal-title":"Brain"},{"issue":"12","key":"524_CR27","doi-asserted-by":"publisher","first-page":"1689","DOI":"10.1002\/mds.21507","volume":"22","author":"M Emre","year":"2007","unstructured":"Emre M, Aarsland D, Brown R, Burn DJ, Duyckaerts C, Mizuno Y, et al. Clinical diagnostic criteria for dementia associated with Parkinson\u2019s disease. Mov Disord. 2007;22(12):1689\u2013707. https:\/\/doi.org\/10.1002\/mds.21507.","journal-title":"Mov Disord"},{"issue":"6","key":"524_CR28","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1212\/wnl.56.6.730","volume":"56","author":"D Aarsland","year":"2001","unstructured":"Aarsland D, Andersen K, Larsen JP, Lolk A, Nielsen H, Kragh\u2013S\u00f8rensen P. Risk of dementia in Parkinson\u2019s disease: a community-based, prospective study. Neurology. 2001;56(6):730\u20136. https:\/\/doi.org\/10.1212\/wnl.56.6.730.","journal-title":"Neurology"},{"issue":"3","key":"524_CR29","doi-asserted-by":"publisher","first-page":"383","DOI":"10.3233\/JPD-240002","volume":"14","author":"P Borghammer","year":"2024","unstructured":"Borghammer P, Okkels N, Weintraub D. Parkinson\u2019s disease and dementia with Lewy bodies: one and the same. J Parkinson\u2019s Dis. 2024;14(3):383\u201397. https:\/\/doi.org\/10.3233\/JPD-240002.","journal-title":"J Parkinson\u2019s Dis"},{"issue":"10","key":"524_CR30","doi-asserted-by":"publisher","first-page":"2160","DOI":"10.1212\/wnl.43.2.250","volume":"43","author":"GC Rom\u00e1n","year":"1993","unstructured":"Rom\u00e1n GC, Tatemichi TK. Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop. Neurology. 1993;43(10):2160\u20132160. https:\/\/doi.org\/10.1212\/wnl.43.2.250.","journal-title":"Neurology"},{"issue":"10004","key":"524_CR31","doi-asserted-by":"publisher","first-page":"1698","DOI":"10.1016\/s0140-6736(15)00463-8","volume":"386","author":"JT O\u2019Brien","year":"2015","unstructured":"O\u2019Brien JT, Thomas A. Vascular dementia. Lancet. 2015;386(10004):1698\u2013706. https:\/\/doi.org\/10.1016\/s0140-6736(15)00463-8.","journal-title":"Lancet"},{"issue":"5","key":"524_CR32","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1016\/j.bbadis.2016.01.015","volume":"1862","author":"RN Kalaria","year":"2016","unstructured":"Kalaria RN, Akinyemi R, Ihara M. Stroke injury, cognitive impairment and vascular dementia. Biochim Biophys Acta (BBA)-Mol Basis Dis. 2016;1862(5):915\u201325. https:\/\/doi.org\/10.1016\/j.bbadis.2016.01.015.","journal-title":"Biochim Biophys Acta (BBA)-Mol Basis Dis"},{"issue":"2","key":"524_CR33","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1001\/archneur.60.2.164","volume":"60","author":"JY Chong","year":"2003","unstructured":"Chong JY, Rowland LP, Utiger RD. Hashimoto encephalopathy: syndrome or myth? Arch Neurol. 2003;60(2):164\u201371. https:\/\/doi.org\/10.1001\/archneur.60.2.164.","journal-title":"Arch Neurol"},{"issue":"2","key":"524_CR34","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.jns.2003.09.007","volume":"217","author":"F Ferracci","year":"2004","unstructured":"Ferracci F, Bertiato G, Moretto G. Hashimoto\u2019s encephalopathy: epidemiologic data and pathogenetic considerations. J Neurol Sci. 2004;217(2):165\u20138. https:\/\/doi.org\/10.1016\/j.jns.2003.09.007.","journal-title":"J Neurol Sci"},{"issue":"1","key":"524_CR35","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1212\/CON.0000000000000688","volume":"25","author":"GS Day","year":"2019","unstructured":"Day GS. Reversible dementias. CONTINUUM Lifelong Learn Neurol. 2019;25(1):234\u201353. https:\/\/doi.org\/10.1212\/CON.0000000000000688.","journal-title":"CONTINUUM Lifelong Learn Neurol"},{"key":"524_CR36","doi-asserted-by":"publisher","DOI":"10.1227\/01.neu.0000168185.29659.c5","author":"N Relkin","year":"2005","unstructured":"Relkin N, Marmarou A, Klinge P, Bergsneider M, Black PM. Diagnosing idiopathic normal-pressure hydrocephalus. Neurosurgery. 2005. https:\/\/doi.org\/10.1227\/01.neu.0000168185.29659.c5.","journal-title":"Neurosurgery"},{"key":"524_CR37","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.c3109","author":"MJ Novak","year":"2010","unstructured":"Novak MJ, Tabrizi SJ. Huntington\u2019s disease. BMJ. 2010. https:\/\/doi.org\/10.1136\/bmj.c3109.","journal-title":"BMJ"},{"issue":"10","key":"524_CR38","doi-asserted-by":"publisher","first-page":"1652","DOI":"10.1038\/s12276-020-00513-7","volume":"52","author":"M Jo","year":"2020","unstructured":"Jo M, Lee S, Jeon YM, et al. The role of TDP-43 propagation in neurodegenerative diseases: integrating insights from clinical and experimental studies. Exp Mol Med. 2020;52(10):1652\u201362. https:\/\/doi.org\/10.1038\/s12276-020-00513-7.","journal-title":"Exp Mol Med"},{"issue":"1","key":"524_CR39","doi-asserted-by":"publisher","DOI":"10.1186\/s13024-025-00851-y","volume":"20","author":"J Rummens","year":"2025","unstructured":"Rummens J, Da Cruz S. RNA-binding proteins in ALS and FTD: from pathogenic mechanisms to therapeutic insights. Mol Neurodegener. 2025;20(1):64. https:\/\/doi.org\/10.1186\/s13024-025-00851-y.","journal-title":"Mol Neurodegener"},{"issue":"8","key":"524_CR40","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1002\/acn3.325","volume":"3","author":"LH Meeter","year":"2016","unstructured":"Meeter LH, Dopper EG, Jiskoot LC, Sanchez\u2010Valle R, Graff C, Benussi L, et al. Neurofilament light chain: a biomarker for genetic frontotemporal dementia. Ann Clin Transl Neurol. 2016;3(8):623\u201336. https:\/\/doi.org\/10.1002\/acn3.325.","journal-title":"Ann Clin Transl Neurol"},{"issue":"2","key":"524_CR41","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1056\/NEJMoa2003715","volume":"383","author":"T Miller","year":"2020","unstructured":"Miller T, Cudkowicz M, Shaw PJ, Andersen PM, Atassi N, Bucelli RC, et al. Phase 1\u20132 trial of antisense oligonucleotide tofersen for SOD1 ALS. N Engl J Med. 2020;383(2):109\u201319. https:\/\/doi.org\/10.1056\/NEJMoa2003715.","journal-title":"N Engl J Med"},{"issue":"3","key":"524_CR42","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1093\/brain\/awaa033","volume":"143","author":"WR Bevan-Jones","year":"2020","unstructured":"Bevan-Jones WR, Cope TE, Jones PS, Kaalund SS, Passamonti L, Allinson K, et al. Neuroinflammation and protein aggregation co-localize across the frontotemporal dementia spectrum. Brain. 2020;143(3):1010\u201326. https:\/\/doi.org\/10.1093\/brain\/awaa033.","journal-title":"Brain"},{"issue":"11","key":"524_CR43","doi-asserted-by":"publisher","first-page":"2218","DOI":"10.1002\/alz.12638","volume":"18","author":"D Eratne","year":"2022","unstructured":"Eratne D, Loi SM, Li QX, Stehmann C, Malpas CB, Santillo A, et al. Cerebrospinal fluid neurofilament light chain differentiates primary psychiatric disorders from rapidly progressive, Alzheimer\u2019s disease and frontotemporal disorders in clinical settings. Alzheimer\u2019s Dement. 2022;18(11):2218\u201333. https:\/\/doi.org\/10.1002\/alz.12638.","journal-title":"Alzheimer's Dement"},{"key":"524_CR44","doi-asserted-by":"publisher","first-page":"1382593","DOI":"10.3389\/fnagi.2024.1382593","volume":"16","author":"JLP Fieldhouse","year":"2024","unstructured":"Fieldhouse JLP, van Paassen DN, van Engelen MPE, De Boer SCM, Hartog WL, Braak S, et al. The pursuit for markers of disease progression in behavioral variant frontotemporal dementia: a scoping review to optimize outcome measures for clinical trials. Front Aging Neurosci. 2024;16:1382593. https:\/\/doi.org\/10.3389\/fnagi.2024.1382593.","journal-title":"Front Aging Neurosci"},{"issue":"5","key":"524_CR45","doi-asserted-by":"publisher","first-page":"754","DOI":"10.3390\/diagnostics11050754","volume":"11","author":"V Davy","year":"2021","unstructured":"Davy V, Dumurgier J, Fayosse A, Paquet C, Cognat E. Neurofilaments as emerging biomarkers of neuroaxonal damage to differentiate behavioral frontotemporal dementia from primary psychiatric disorders: a systematic review. Diagnostics. 2021;11(5):754. https:\/\/doi.org\/10.3390\/diagnostics11050754.","journal-title":"Diagnostics"},{"issue":"1","key":"524_CR46","doi-asserted-by":"publisher","first-page":"113","DOI":"10.3233\/JAD-180657","volume":"67","author":"S Ducharme","year":"2019","unstructured":"Ducharme S, Pearl-Dowler L, Gossink F, McCarthy J, Lai J, Dickerson BC, et al. The frontotemporal dementia versus primary psychiatric disorder (FTD versus PPD) checklist: a bedside clinical tool to identify behavioral variant FTD in patients with late-onset behavioral changes. J Alzheimer\u2019s Dis. 2019;67(1):113\u201324. https:\/\/doi.org\/10.3233\/JAD-180657.","journal-title":"J Alzheimer\u2019s Dis"},{"issue":"4","key":"524_CR47","first-page":"276","volume":"2","author":"ML Wald\u00f6","year":"2013","unstructured":"Wald\u00f6 ML, Gustafson L, Nilsson K, Traynor BJ, Renton AE, Englund E, et al. Frontotemporal dementia with a C9ORF72 expansion in a Swedish family: clinical and neuropathological characteristics. Am J Neurodegener Dis. 2013;2(4):276.","journal-title":"Am J Neurodegener Dis"},{"issue":"5","key":"524_CR48","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1002\/ana.24273","volume":"76","author":"NG Simon","year":"2014","unstructured":"Simon NG, Turner MR, Vucic S, Al-Chalabi A, Shefner J, Lomen-Hoerth C, et al. Quantifying disease progression in amyotrophic lateral sclerosis. Ann Neurol. 2014;76(5):643\u201357.","journal-title":"Ann Neurol"},{"issue":"2","key":"524_CR49","first-page":"84","volume":"3","author":"ML Wald\u00f6","year":"2014","unstructured":"Wald\u00f6 ML, Santillo AF, Gustafson L, Englund E, Passant U. Somatic complaints in frontotemporal dementia. Am J Neurodegener Dis. 2014;3(2):84.","journal-title":"Am J Neurodegener Dis"},{"issue":"9","key":"524_CR50","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1136\/jnnp-2013-306995","volume":"85","author":"LE Downey","year":"2014","unstructured":"Downey LE, Fletcher PD, Golden HL, Mahoney CJ, Agustus JL, Schott JM, et al. Altered body schema processing in frontotemporal dementia with C9ORF72 mutations. J Neurol Neurosurg Psychiatry. 2014;85(9):1016\u201323.","journal-title":"J Neurol Neurosurg Psychiatry"}],"container-title":["Discover Mental Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s44192-026-00524-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s44192-026-00524-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s44192-026-00524-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T12:03:11Z","timestamp":1790164991000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s44192-026-00524-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,25]]},"references-count":50,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["524"],"URL":"https:\/\/doi.org\/10.1007\/s44192-026-00524-2","relation":{},"ISSN":["2731-4383"],"issn-type":[{"value":"2731-4383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,25]]},"assertion":[{"value":"5 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the Ethics Committee of Tehran University of Medical Sciences (TUMS), Tehran, Iran (IR.TUMS.MEDICINE.REC.1404.251). The study was conducted in accordance with the Declaration of Helsinki.","order":1,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Written informed consent was obtained from the patient.","order":2,"name":"Ethics","label":"Consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not Applicable.","order":3,"name":"Ethics","label":"Consent to publish","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":4,"name":"Ethics","label":"Clinical trial number","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The lead author, Faezeh Khorshidian, affirms that this manuscript is an honest, accurate, and transparent account of the study being reported; that no important aspects of the study have been omitted; and that any discrepancies from the study as planned (and, if relevant, registered) have been explained.","order":5,"name":"Ethics","label":"Transparency statement","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":6,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"177"}}